According to the literature, a retrospective study assessed the frequency of major complications following the treatment of liver tumors with multiprobe stereotactic radiofrequency ablation (srfa) between july 2003 and december 2018.It is noted that a maximum of three 17g cool-tip radiofrequency (rf) electrodes were introduced through coaxial needles for serial tumor ablation, which was further carried out using the unipolar cool-tip rf generator and cool-tip rf switching controller.There were 793 patients treated in 1235 srfa sessions and complications included: thermal damage to hollow viscera, skin, and central bile ducts, which required additional surgery and/or endoscopic retrograde cholangiopancreatography (ercp ) with ultrasound (us)-guided drainage, pleuro-cutaneous fistula secondary to thermal injury, treated with a series of us-guided drainages, liver abscesses treated with surgical intervention or us-guided drainage,<(>,<)> arterio-portal fistula treated with angiographic coiling, peri-intrahepatic hemorrhage treated with angiographic coiling, major pleural effusion treated with thoracocentesis, and pneumothorax treated with chest tube insertion.
|
This event has been reassessed and found to be a non-mdr reportable complaint.The issue being reported is not associated with a serious injury or potential for serious injury with reoccurrence.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|